Completeomics
Founded 2019 · 14 employees on LinkedIn · 1 known investors
Find your way into Completeomics
Sign up to see every warm intro you have to Completeomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Completeomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Complete Omics develops a clinical proteomics platform that identifies patient-specific neoantigens to enable personalized cancer therapeutics. The platform guides the design of targeted treatments such as mRNA vaccines and cell therapies.
Founders & leadership
Completeomics was founded in 2019 by Ming Zhang.
MZ
Ming ZhangCo-Founder and Chief Intellectual Property Officer
Investors · 1
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Completeomics do?
- Complete Omics develops a clinical proteomics platform that identifies patient-specific neoantigens to enable personalized cancer therapeutics. The platform guides the design of targeted treatments such as mRNA vaccines and cell therapies.
- Who founded Completeomics?
- Completeomics was founded by Ming Zhang in 2019.
- Who are Completeomics's investors?
- Completeomics's investors include Qiming Venture Partners.

